| pubmed-article:8418221 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
| pubmed-article:8418221 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:8418221 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8418221 | pubmed:dateCreated | 1993-2-2 | lld:pubmed |
| pubmed-article:8418221 | pubmed:abstractText | Between May 1980 and September 1990, 85 patients with Hodgkin's disease were treated with a regimen designed to increase cure rates while reducing late toxicity. | lld:pubmed |
| pubmed-article:8418221 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8418221 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8418221 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8418221 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8418221 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8418221 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8418221 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:WilimasJJ | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:ThompsonEE | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:KauffmanWW | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:FaircloughDD | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:MarinaNN | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:AbromowitchMM | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:HudsonM MMM | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:MackertP WPW | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:GreenwaldCC | lld:pubmed |
| pubmed-article:8418221 | pubmed:author | pubmed-author:BozemanPP | lld:pubmed |
| pubmed-article:8418221 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8418221 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:8418221 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8418221 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:8418221 | pubmed:pagination | 100-8 | lld:pubmed |
| pubmed-article:8418221 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:meshHeading | pubmed-meshheading:8418221-... | lld:pubmed |
| pubmed-article:8418221 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8418221 | pubmed:articleTitle | Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. | lld:pubmed |
| pubmed-article:8418221 | pubmed:affiliation | Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38101. | lld:pubmed |
| pubmed-article:8418221 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8418221 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8418221 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8418221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8418221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8418221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8418221 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8418221 | lld:pubmed |
